Low-level, progestogen-releasing vaginal contraceptive devices.
Silicone rubber vaginal contraceptive devices of four different formulations, which release predetermined, controlled doses of three progestogens at four distinct levels, were designed and fabricated, and tested in 90-day clinical trials. Data obtained with 70 of the devices indicated that in vivo release rates (microgram/day +/- S.D.) for the formulations were: progesterone, 1400 +/- 30; norethindrone (two levels), 49.4 +/- 2.4, 196 +/- 21; d-norgestrel, 21.6 +/- 1.4. Clinical studies with these devices indicate that the women usually ovulate (with the exception of the high-dose norethindrone-releasing devices) while sperm penetration of the cervix was inhibited by all four fromulations, most consistently by the norgestrel-releasing devices.
D003273:Contraceptive Devices; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D009640:Norethindrone / Q000008:administration & dosage; D009644:Norgestrel / Q000008:administration & dosage; D011309:Preservation, Biological; D011374:Progesterone / Q000008:administration & dosage; D011372:Progestins / Q000008:administration & dosage*
D011372:Progestins; D009644:Norgestrel; D011374:Progesterone; D009640:Norethindrone